featured resource
What’s the connection between GLP-1s and gallbladder disease? Understand what drives this risk, and find out how care teams address it.
What happens when you stop semaglutide, exactly? Discover what occurs beneath the surface, and learn tips for discontinuing treatment with confidence.
How safe and effective is Wegovy® for binge eating disorder (BED)? Research in this area is limited but promising. Discover what it indicates.
What happens when you stop taking Zepbound®, exactly? Find out what to expect and how to maintain your progress after discontinuation.
Wondering what to do when GLP-1 stops working? Learn why weight loss plateaus, how to tell if treatment still works, and when to talk with your provider.
Compare Foundayo® versus Zepbound® for weight loss. Discover the potential benefits and risks of both FDA-approved prescription medications.
Thinking of starting GLP-1? Explore what to expect in the early stages of treatment, and learn tips for managing this period with confidence.
Understanding what GLP-1s can do is only part of the picture. Clinicians also need to understand the person taking them — and how metabolic health plays a role in every stage of a person's health journey.
How effective is Foundayo® for weight loss? Discover what clinical research indicates and whether this GLP-1 RA makes sense for your care plan.
Comparing Wegovy® versus Alli® for weight loss? Discover key weight loss outcomes for both medications, plus potential risk factors to consider.
See how tirzepatide versus liraglutide compare for weight loss, from clinical trial results and dosing schedules to side effects and safety.
Comparing Zepbound® vs. Contrave® for weight loss? Discover key clinical outcomes, plus the risks that factor into any treatment decision.
Explore Contrave® versus Wegovy® to learn how each medication works, what their trade-offs are, and which one may be a better fit for your goals.
Comparing tirzepatide vs exenatide? Discover how both medications work, what clinical research shows, and which risk factors exist to make your decision.
Compare retatrutide versus tirzepatide as the newest GLP-1 approaches FDA approval. Review mechanisms of action, clinical trial data, and safety profiles.
Learn the differences between Zepbound® versus retatrutide. Find out how each drug works and what they’re approved for to choose the right option for you.
Does Zepbound® help with menopause? Learn how tirzepatide fits into a midlife care plan to address weight gain driven by hormonal shifts.
Weighing Qsymia® versus Wegovy®? Learn how they compare on weight loss, side effects, and cost to find the option that best fits your goals.
Comparing semaglutide versus tirzepatide? Here’s a clear look at weight loss results, side effects, and cardiovascular outcomes from head-to-head trials.
Wondering about Wegovy® and estrogen? See what research says about combining GLP-1s with HRT during menopause, and learn what to ask your doctor.
Discover what the research says about Saxenda® versus Wegovy®, and decide which FDA-approved GLP-1 RA for weight loss is right for you.
Foundayo® (orforglipron) is the newest FDA-approved GLP-1 pill. Compare orforglipron versus semaglutide, from approved indications to side effect risk.
Which tirzepatide side effects are normal? Learn what to expect during treatment, how to relieve common reactions, and when to talk to your provider.
On Ozempic®, nausea relief often comes as you settle into your maintenance dose. Learn how to manage your symptoms safely and effectively while they last.
Learn the difference between orforglipron versus tirzepatide. Both are GLP-1 drugs, but tirzepatide targets two receptors for nearly double the weight loss.
Compare compounded tirzepatide versus Zepbound®: safety concerns, cost differences, and what the FDA’s restrictions mean for your care.
Can GLP-1 RAs affect your period? Learn why some people see their menstrual cycles normalize while others don’t. Discover how Maven Clinic can help.
Build a diet after Ozempic that keeps your appetite in check and protects your results. Get evidence-based nutrition tips for lasting weight maintenance.
Considering GLP-1 injections? Learn exactly how they work, common side effects, and how patients use them for weight loss and diabetes care.
Discover the differences between Zepbound® vs. Ozempic®. Find out how to get the right GLP-1 treatment for your needs with Maven Clinic.
Zepbound and Wegovy are FDA-approved for weight loss. Compare how they work, evaluate their effectiveness, and learn how Maven Clinic can help you pick.
Does Ozempic cause hair loss? Learn what the research shows and how Maven Clinic specialists can help you manage any hair loss you might be experiencing.
Learn about GLP-1 medications and the conditions they treat. Plus, hear more about their side effects and the role they can play in whole-person care.
Learn more about weight management after semaglutide and pregnancy. Find out how to build a weight-loss plan that actually works postpartum.
Find out the causes of a weight plateau while exercising, from metabolic adaptation to poor sleep, and learn how to get your progress back on track.
Explore how hormone replacement therapy for weight loss supports metabolic health, helps manage menopause weight gain, and improves daily well-being.
Sudden weight gain after 40 can happen even when habits stay the same. Learn how hormones, metabolism, and sleep influence midlife weight changes.
Find out how to manage common GLP-1 RA side effects. Get expert tips on safety and what to expect during your metabolic health journey.
Insurance coverage for weight loss drugs like Wegovy® and Zepbound® varies widely. Here’s what to check before starting GLP-1 treatment.
Discover more about sustainable weight loss methods, and learn how to achieve lasting results with the support of Maven Clinic’s expert team.
Is keeping weight off after semaglutide possible? Discover what the research shows, from the role of lifestyle interventions to whole-person care.
Considering GLP-1s for weight loss? Discover how they work in women, safety considerations, and how to access medically supervised care.